0.205

2.52% -0.0054

Catheter Precision Inc. (VTAK)

Overview News Price History Discussions Forecast

Catheter Precision Inc. stock is traded at $0.205, with a volume of 96,225. It is down -2.52% in the last 24 hours and down -58.47% over the past month. Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Previous Close:

$0.2104

Open:

$0.21

24h Volume:

96,225

Relative Volume:

0.01

Market Cap:

$743.55K

Revenue:

$819.00K

Net Income/Loss:

$-17.70M

P/E Ratio:

-0.0162

EPS:

-12.6647

Net Cash Flow:

$-8.45M

1W Performance:

-26.75%

1M Performance:

-58.47%

6M Performance:

-87.64%

1Y Performance:

-93.12%

1-Day Range:

$0.204

$0.21

1-Week Range:

$0.1889

$0.2494

52-Week Range:

$0.1889

$3.20

Catheter Precision Inc. Stock (VTAK) Company Profile

Name

Catheter Precision Inc.

Sector

Healthcare (1083)

Industry

Medical Devices (140)

Phone

973 691 2000

Address

1670 Highway 160 West, Suite 205, Fort Mill

Employee

Twitter

Next Earnings Date

2026-08-17

Latest SEC Filings

VTAK's Discussions on Twitter

Compare VTAK vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VTAK Catheter Precision Inc.	0.206	769.90K	819.00K	-17.70M	-8.45M	-12.66
ABT Abbott Laboratories	114.75	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.92	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.36	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.62	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.54	53.19B	6.30B	1.07B	1.09B	1.8406

Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-19	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-02-18	Initiated	Maxim Group	Buy

Catheter Precision Inc. Stock (VTAK) Latest News

Aug 20, 2026

INFQ, VTAK, ORIS: Why These Stocks Posted Double-Digit Gains After-Hours Today - Stocktwits

Aug 19, 2026

Aug 18, 2026

Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market - marketscreener.com

Aug 18, 2026

Catheter Precision earnings beat by $17.54, revenue fell short of estimates - Investing.com Nigeria

Aug 18, 2026

Catheter Precision (VTAK) Edges Lower but Holds Tight Range Between $0.22 and $0.24Vanna Flow - Vinanet

Aug 18, 2026

Aug 16, 2026

Catheter Precision (VTAK) Dips 3.45% to $0.28 as Bulls Defend Key SupportBlue Chip Entry Points - Vinanet

Aug 16, 2026

Aug 14, 2026

Catheter Precision (VTAK) Releases Q2 2026 Earnings: Revenue Up Sharply but Below Estimates - Quiver Quantitative

Aug 14, 2026

Catheter Precision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Aug 13, 2026

VTAK Q1 2025 Earnings: 71.6% EPS Surprise Miss Weighs on SharesManagement Guidance Update - Vinanet

Aug 13, 2026